Read also: AbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small cell lung cancer "We are pleased to announce the acquisition of Aliada by AbbVie and are ...

a Represents net earnings attributable to AbbVie Inc. Acquisition and integration costs primarily reflect integration costs related to the Allergan acquisition, including a one-time gain of $169 ...

a Represents net earnings attributable to AbbVie Inc. Acquisition and integration costs primarily reflect integration costs related to the Allergan acquisition, including a one-time gain ...

The acquisition will include Aliada’s ALIA-1758, which is in development for Alzheimer’s disease. Credit: Art_Photo/Shutterstock. AbbVie has entered a definitive agreement to acquire all outstanding ...

A council plans on battling “the plague” of shopping trolleys dumped in its rivers and streets by hitting supermarkets harder in the pocket. A wildlife reserve visitor centre has been damaged ...